knowledge -WSS

knowledge

author：leisure time 2025-09-14 18:27:23 - browse：46368

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Covid misinformation case heads to Supreme Court

hotspot

WSS

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Congressmen charge Covid hearing ‘could have been an email’

Google and Epic fight stronger regulation of AI in health care

General Catalyst, Summa Health deal will turn on physician buy

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Listen: Wegovy in the brain & pivotal Alzheimer's data

entertainment

knowledge

explore

Wildfire smoke exposes gaps in outdoor worker protections

General Catalyst, Summa Health deal will turn on physician buy

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Apple Vision Pro: A first look at health apps on the new VR headset

23andMe had bad news about my health. I wish a person had delivered it

Medicare has a new plan to address drug shortages

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Group opposing PBM reform sets lobbying record

Peter Hotez and the public health issue of online harassment

Biden administration opens offers in Medicare drug price negotiations

focus

Vertigo drug brings hope for rare neuron disorder, Niemann

Cosmetics set for new safety regulation. Why the industry is on board

Google and Epic fight stronger regulation of AI in health care

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Juul spent big to court Black leaders to promote its e

Sanders adds drug shortage policies to pandemic preparedness bill

hotspot

Wikipedia

entertainment

hotspot